Cargando…

Is mastocytic colitis a specific clinical-pathological entity?

The number of intestinal mast cells (MC) is increased in several types of colitis, but the mucosa of patients with chronic non-bloody diarrhea has not been studied. The current study sought to determine the relationship between MC counts and degranulation and the severity of symptoms in patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Vernia, Filippo, Tatti, Tiziana, Necozione, Stefano, Capannolo, Annalisa, Cesaro, Nicola, Magistroni, Marco, Valvano, Marco, Pompili, Simona, Sferra, Roberta, Vetuschi, Antonella, Latella, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761410/
https://www.ncbi.nlm.nih.gov/pubmed/36440694
http://dx.doi.org/10.4081/ejh.2022.3499
_version_ 1784852700179988480
author Vernia, Filippo
Tatti, Tiziana
Necozione, Stefano
Capannolo, Annalisa
Cesaro, Nicola
Magistroni, Marco
Valvano, Marco
Pompili, Simona
Sferra, Roberta
Vetuschi, Antonella
Latella, Giovanni
author_facet Vernia, Filippo
Tatti, Tiziana
Necozione, Stefano
Capannolo, Annalisa
Cesaro, Nicola
Magistroni, Marco
Valvano, Marco
Pompili, Simona
Sferra, Roberta
Vetuschi, Antonella
Latella, Giovanni
author_sort Vernia, Filippo
collection PubMed
description The number of intestinal mast cells (MC) is increased in several types of colitis, but the mucosa of patients with chronic non-bloody diarrhea has not been studied. The current study sought to determine the relationship between MC counts and degranulation and the severity of symptoms in patients with chronic loose stools. Following a negative laboratory workup for the most common causes of chronic diarrhea, patients with chronic non-bloody loose stools were included in the study. Patients with macroscopic evidence of inflammation or organic disease were excluded after endoscopy with biopsies. Biopsies from the 179 patients in the study were stained with hematoxylin and eosin and anti-CD117 c-kit antibodies. Immunohistochemistry was used to assess the degree of MC degranulation. Out of the 179 patients, 128 had normal histologic findings suggestive of irritable bowel syndrome and were used as controls. Twenty-four presented with abnormally high MC counts (≥40 MC x HPF), 23 with ≥20 intraepithelial lymphocytes x HPF suggesting lymphocytic colitis, and 4 had both (≥40 MC and ≥20 intraepithelial lymphocytes x HPF). In the patients with high MC counts, figures were significantly higher in the right colon versus the left colon (p=0.016), but degranulation did not differ in the right versus the left colon (p=0.125). No age or sex-related difference was observed (p=0.527 and p=0.859 respectively). The prevalence of abdominal pain and bloating did not differ in the three groups (p=0.959 and p=0.140, respectively). Patients with lymphocytic colitis (p=0.008) and those with high MC count (p=0.025) had significantly higher evacuation rates compared to controls. There was no difference between these two groups (p=0.831). Mast cell degranulation was not associated with the number of evacuations, abdominal pain, or bloating (p=0.51; p=0.41; p=0.42, respectively). The finding that a significantly higher number of evacuations was linked to increased MC in the colonic mucosa of a subset of patients with otherwise normal laboratory and endoscopic findings suggests that "mastocytic colitis" may be a new clinical-pathological entity responsible for chronic non-bloody diarrhea. Prospective studies with a larger number of patients, as well as endoscopic and histological follow-up, are needed to confirm this hypothesis.
format Online
Article
Text
id pubmed-9761410
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher PAGEPress Publications, Pavia, Italy
record_format MEDLINE/PubMed
spelling pubmed-97614102022-12-20 Is mastocytic colitis a specific clinical-pathological entity? Vernia, Filippo Tatti, Tiziana Necozione, Stefano Capannolo, Annalisa Cesaro, Nicola Magistroni, Marco Valvano, Marco Pompili, Simona Sferra, Roberta Vetuschi, Antonella Latella, Giovanni Eur J Histochem Article The number of intestinal mast cells (MC) is increased in several types of colitis, but the mucosa of patients with chronic non-bloody diarrhea has not been studied. The current study sought to determine the relationship between MC counts and degranulation and the severity of symptoms in patients with chronic loose stools. Following a negative laboratory workup for the most common causes of chronic diarrhea, patients with chronic non-bloody loose stools were included in the study. Patients with macroscopic evidence of inflammation or organic disease were excluded after endoscopy with biopsies. Biopsies from the 179 patients in the study were stained with hematoxylin and eosin and anti-CD117 c-kit antibodies. Immunohistochemistry was used to assess the degree of MC degranulation. Out of the 179 patients, 128 had normal histologic findings suggestive of irritable bowel syndrome and were used as controls. Twenty-four presented with abnormally high MC counts (≥40 MC x HPF), 23 with ≥20 intraepithelial lymphocytes x HPF suggesting lymphocytic colitis, and 4 had both (≥40 MC and ≥20 intraepithelial lymphocytes x HPF). In the patients with high MC counts, figures were significantly higher in the right colon versus the left colon (p=0.016), but degranulation did not differ in the right versus the left colon (p=0.125). No age or sex-related difference was observed (p=0.527 and p=0.859 respectively). The prevalence of abdominal pain and bloating did not differ in the three groups (p=0.959 and p=0.140, respectively). Patients with lymphocytic colitis (p=0.008) and those with high MC count (p=0.025) had significantly higher evacuation rates compared to controls. There was no difference between these two groups (p=0.831). Mast cell degranulation was not associated with the number of evacuations, abdominal pain, or bloating (p=0.51; p=0.41; p=0.42, respectively). The finding that a significantly higher number of evacuations was linked to increased MC in the colonic mucosa of a subset of patients with otherwise normal laboratory and endoscopic findings suggests that "mastocytic colitis" may be a new clinical-pathological entity responsible for chronic non-bloody diarrhea. Prospective studies with a larger number of patients, as well as endoscopic and histological follow-up, are needed to confirm this hypothesis. PAGEPress Publications, Pavia, Italy 2022-11-28 /pmc/articles/PMC9761410/ /pubmed/36440694 http://dx.doi.org/10.4081/ejh.2022.3499 Text en ©Copyright: the Author(s) https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Article
Vernia, Filippo
Tatti, Tiziana
Necozione, Stefano
Capannolo, Annalisa
Cesaro, Nicola
Magistroni, Marco
Valvano, Marco
Pompili, Simona
Sferra, Roberta
Vetuschi, Antonella
Latella, Giovanni
Is mastocytic colitis a specific clinical-pathological entity?
title Is mastocytic colitis a specific clinical-pathological entity?
title_full Is mastocytic colitis a specific clinical-pathological entity?
title_fullStr Is mastocytic colitis a specific clinical-pathological entity?
title_full_unstemmed Is mastocytic colitis a specific clinical-pathological entity?
title_short Is mastocytic colitis a specific clinical-pathological entity?
title_sort is mastocytic colitis a specific clinical-pathological entity?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761410/
https://www.ncbi.nlm.nih.gov/pubmed/36440694
http://dx.doi.org/10.4081/ejh.2022.3499
work_keys_str_mv AT verniafilippo ismastocyticcolitisaspecificclinicalpathologicalentity
AT tattitiziana ismastocyticcolitisaspecificclinicalpathologicalentity
AT necozionestefano ismastocyticcolitisaspecificclinicalpathologicalentity
AT capannoloannalisa ismastocyticcolitisaspecificclinicalpathologicalentity
AT cesaronicola ismastocyticcolitisaspecificclinicalpathologicalentity
AT magistronimarco ismastocyticcolitisaspecificclinicalpathologicalentity
AT valvanomarco ismastocyticcolitisaspecificclinicalpathologicalentity
AT pompilisimona ismastocyticcolitisaspecificclinicalpathologicalentity
AT sferraroberta ismastocyticcolitisaspecificclinicalpathologicalentity
AT vetuschiantonella ismastocyticcolitisaspecificclinicalpathologicalentity
AT latellagiovanni ismastocyticcolitisaspecificclinicalpathologicalentity